Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

2.

Phosphorylation of the human retinoid X receptor alpha at serine 260 impairs coactivator(s) recruitment and induces hormone resistance to multiple ligands.

Macoritto M, Nguyen-Yamamoto L, Huang DC, Samuel S, Yang XF, Wang TT, White JH, Kremer R.

J Biol Chem. 2008 Feb 22;283(8):4943-56. Epub 2007 Nov 14.

3.

Vitamin D resistance in RAS-transformed keratinocytes: mechanism and reversal strategies.

Solomon C, Kremer R, White JH, Rhim JS.

Radiat Res. 2001 Jan;155(1 Pt 2):156-162.

PMID:
11121228
4.
5.

Resistance of HBL100 human breast epithelial cells to vitamin D action.

Agadir A, Lazzaro G, Zheng Y, Zhang XK, Mehta R.

Carcinogenesis. 1999 Apr;20(4):577-82.

6.

Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene.

MacDonald PN, Dowd DR, Nakajima S, Galligan MA, Reeder MC, Haussler CA, Ozato K, Haussler MR.

Mol Cell Biol. 1993 Sep;13(9):5907-17.

7.

Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors.

Fernandez-Martin JL, Kurian S, Farmer P, Nanes MS.

Mol Cell Endocrinol. 1998 Jun 25;141(1-2):65-72.

PMID:
9723887
8.

Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts.

Thompson PD, Remus LS, Hsieh JC, Jurutka PW, Whitfield GK, Galligan MA, Encinas Dominguez C, Haussler CA, Haussler MR.

J Mol Endocrinol. 2001 Oct;27(2):211-27.

11.
12.

Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.

Whitfield GK, Selznick SH, Haussler CA, Hsieh JC, Galligan MA, Jurutka PW, Thompson PD, Lee SM, Zerwekh JE, Haussler MR.

Mol Endocrinol. 1996 Dec;10(12):1617-31.

PMID:
8961271
13.

Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.

Herdick M, Steinmeyer A, Carlberg C.

Chem Biol. 2000 Nov;7(11):885-94.

14.

Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.

Verlinden L, Verstuyf A, Quack M, Van Camp M, Van Etten E, De Clercq P, Vandewalle M, Carlberg C, Bouillon R.

J Bone Miner Res. 2001 Apr;16(4):625-38.

15.

Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.

Pathrose P, Barmina O, Chang CY, McDonnell DP, Shevde NK, Pike JW.

J Bone Miner Res. 2002 Dec;17(12):2196-205. Erratum in: J Bone Miner Res. 2003 Feb;18(2):390.

18.
20.

Stress pathway activation induces phosphorylation of retinoid X receptor.

Lee HY, Suh YA, Robinson MJ, Clifford JL, Hong WK, Woodgett JR, Cobb MH, Mangelsdorf DJ, Kurie JM.

J Biol Chem. 2000 Oct 13;275(41):32193-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk